Cancer experts angry over patient treatment
Updated on 24 August 2008
Leading UK cancer experts have accused a health watchdog of forcing patients to remortgage their homes to afford treatments freely available in Europe.
The group of 26 professors were "dismayed" at guidance issued by the National Institute for Health and Clinical Excellence (Nice) to deny patients four kidney cancer drugs on the NHS.
They said the decision showed it was time for a "radical change" in how the NHS makes decisions on what treatments are available for cancer sufferers.
In a letter to a Sunday newspaper, the consultants said: "We are dismayed at the decision by the National Institute of Health and Clinical Excellence (Nice) on the rationing of drugs for patients with advanced kidney cancer."
The Nice draft guidance, which is subject to appeal, rejects the drugs, saying they are not cost effective for patients with advanced and/or metastatic kidney cancer.
The medicines do not cure the cancer but extend a person's life by a matter of months.
But the professors wrote: "Once again Nice has shown how poorly it assesses new cancer treatments.
"Its economic formulae are simply not suitable for addressing cost effectiveness in this area of medicine.
"Mean survivals obscure the fact that some patients will obtain prolonged benefit from these drugs."
The effect of the guidance would be to force patients to fund their own treatment, the oncologists argued.
© Independent Television News Limited 2008. All rights reserved.
These news feeds are provided by an independent third party and Channel 4 is not responsible or liable to you for the same.
